Deep Track Capital

Funding rounds backed by Deep Track Capital.

Export CSV
Funding disclosed in full
$338M
Median round
$82.5M
Rounds in calculation
4
4 rounds
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Draig Therapeutics

Developing transformative, best-in-class neuropsychiatric therapies

$65MSeries BBiotechUnited Kingdom
12 participantsAccess BiotechnologyBritish Business BankCanaan PartnersDeep Track CapitalICGJanus Henderson InvestorsJefferson Life SciencesMarshall WaceSanofi VenturesSchroders CapitalSR OneSV Health Investors
Triveni Bio

Develops novel antibody treatments for immunological and inflammatory disorders

$65MSeries CBiotechUnited States
7 participantsAlexandria VentureAscenta CapitalAtlas VentureDeep Track CapitalFidelityGoldman SachsJanus Henderson Investors
Terremoto Biosciences

Develops highly targeted, small molecule medicines for cancer and rare diseases

$108MSeries CBiotechUnited States
8 participantsBeOne MedicinesCormorant Asset ManagementDeep Track CapitalNovo HoldingsOrbiMedOsage University Partners (OUP)RA Capital ManagementThird Rock Ventures
Ambrosia Biosciences

Develops orally delivered, small molecule-based therapies for obesity and other metabolic disorders

$100MSeries BBiotechUnited States
7 participantsBlue Owl Healthcare OpportunitiesBoulder VenturesBVF PartnersDeep Track CapitalJanus Henderson InvestorsRedmileSamsara BioCapital